AIG
ABCL icon

American International Group’s AbCellera Biologics ABCL Stock Holding History

American International Group’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-99,952
Closed -$754K – 3073
2023
Q1 		$754K Buy
99,952
+1,989
+2% +$18.1K ﹤0.01% 1378
2022
Q4 		$992K Sell
97,963
-356
-0.4% -$4.11K 0.01% 1211
2022
Q3 		$972K Buy
98,319
+1,389
+1% +$15.2K 0.01% 1191
2022
Q2 		$1.03M Buy
+96,930
New +$821K 0.01% 1185

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

American International Group's ABCL Position: Q2 2023 in Review

American International Group sold out of AbCellera Biologics (ABCL) in Q2 2023, closing a stake of 99,952 shares — an estimated $754K sold.

American International Group first reported a position in ABCL in Q2 2022 and held it in 4 quarters. The position peaked at $1.03M in Q2 2022. 169 funds tracked by Wall St. Rank hold ABCL as of Q2 2023.

  • American International Group reported no remaining AbCellera Biologics position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 99,952 AbCellera Biologics shares in Q2 2023, an estimated $754K.
  • American International Group first reported a position in AbCellera Biologics in Q2 2022 and held it in 4 quarters.
  • American International Group's AbCellera Biologics position peaked at $1.03M in Q2 2022.
  • 169 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.